Skip to main content

The treatment of ankylosing spondylitis

Abstract.

Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery. Symptoms can often be debilitating. Current therapy for the disease include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDS, anti-rheumatic disease modifying drugs (DMARDS), and the newly developed biologic agents targeting tumor necrosis factor alpha (TNF-α). This paper will provide a comprehensive review of these treatments which focusing on evidence based medicine for the daily clinical practice of rheumatology.

This is a preview of subscription content, access via your institution.

Author information

Authors and Affiliations

Authors

Additional information

Received: 31 December 2002 / Accepted: 15 January 2003

Correspondence to J.C. Davis Jr.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Scalapino, K., Davis Jr., J. The treatment of ankylosing spondylitis. Clin Exp Med 2, 159–165 (2003). https://doi.org/10.1007/s102380300000

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s102380300000

  • Key words Ankylosing spondylitis
  • Medical therapies
  • NSAIDS
  • Physical therapy
  • Sulfasalazine
  • Pamidronate
  • Thalidomide
  • Methotrexate
  • Biologic agents
  • TNF